Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.87 -0.06 (-0.55%)
As of: Oct 2, 2026 · 11:38 AM EDT

Corvus Pharmaceuticals (CRVS) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Corvus Pharmaceuticals (CRVS) posted Depreciation & Amortization (CF) of $34,000 for Q2 2026, up 17.2% from $29,000 a year earlier and up 17.2% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Corvus Pharmaceuticals was $117,000, up 27.2% year-over-year; for FY2025, it came in at $105,000, up 23.5% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -30.2% (FY2020 to FY2025).
  • In prior years, Corvus Pharmaceuticals' Depreciation & Amortization (CF) was $85,000 in FY2024 (-43.7%), $151,000 in FY2023 (-58.9%), $367,000 in FY2022 (-20.2%) and $460,000 in FY2021 (-27.2%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q2 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last five quarters, with growth averaging 10.9% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2025, with growth of 38.1%; the weakest was Q4 2023, with a decline of 70.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $29,000 (Q1 2026), $26,000 (Q4 2025) and $28,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Corvus Pharmaceuticals 969.07 Mn 457.51 Mn - 34,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34,000.00
Mar 31, 2026 29,000.00
Dec 31, 2025 26,000.00
Sep 30, 2025 28,000.00
Jun 30, 2025 29,000.00
Mar 31, 2025 22,000.00
Dec 31, 2024 20,000.00
Sep 30, 2024 21,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 23,000.00
Dec 31, 2023 28,000.00
Sep 30, 2023 30,000.00
Jun 30, 2023 36,000.00
Mar 31, 2023 57,000.00
Dec 31, 2022 94,000.00
Sep 30, 2022 94,000.00
Jun 30, 2022 92,000.00
Mar 31, 2022 87,000.00
Dec 31, 2021 93,000.00
Sep 30, 2021 108,000.00
API Access

Corvus Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRVS&period=max&api_key=YOUR_API_KEY